nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—CYP2C9—brain cancer	0.588	1	CbGaD
Enzalutamide—CYP2D6—Lomustine—brain cancer	0.0665	0.231	CbGbCtD
Enzalutamide—CYP2D6—Hydroxyurea—brain cancer	0.0504	0.175	CbGbCtD
Enzalutamide—CYP3A4—Temozolomide—brain cancer	0.0497	0.173	CbGbCtD
Enzalutamide—CYP3A4—Lomustine—brain cancer	0.0423	0.147	CbGbCtD
Enzalutamide—CYP3A5—Etoposide—brain cancer	0.0262	0.0911	CbGbCtD
Enzalutamide—CYP2C8—Etoposide—brain cancer	0.0252	0.0876	CbGbCtD
Enzalutamide—ABCB1—Etoposide—brain cancer	0.0171	0.0593	CbGbCtD
Enzalutamide—CYP3A4—Etoposide—brain cancer	0.0102	0.0355	CbGbCtD
Enzalutamide—Lung infection—Temozolomide—brain cancer	0.00592	0.0837	CcSEcCtD
Enzalutamide—Bicalutamide—CYP2C9—brain cancer	0.00404	0.608	CrCbGaD
Enzalutamide—Nilutamide—CYP2C9—brain cancer	0.0026	0.392	CrCbGaD
Enzalutamide—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00188	0.0401	CbGpPWpGaD
Enzalutamide—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00169	0.0361	CbGpPWpGaD
Enzalutamide—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.00155	0.033	CbGpPWpGaD
Enzalutamide—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00154	0.0328	CbGpPWpGaD
Enzalutamide—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00151	0.0322	CbGpPWpGaD
Enzalutamide—AR—Coregulation of Androgen receptor activity—KDM4C—brain cancer	0.00139	0.0296	CbGpPWpGaD
Enzalutamide—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00138	0.0293	CbGpPWpGaD
Enzalutamide—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00131	0.028	CbGpPWpGaD
Enzalutamide—Memory impairment—Temozolomide—brain cancer	0.00124	0.0175	CcSEcCtD
Enzalutamide—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00117	0.025	CbGpPWpGaD
Enzalutamide—Disturbance in attention—Temozolomide—brain cancer	0.00112	0.0159	CcSEcCtD
Enzalutamide—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.00108	0.0229	CbGpPWpGaD
Enzalutamide—Infection—Carboplatin—brain cancer	0.00102	0.0145	CcSEcCtD
Enzalutamide—Leukopenia—Lomustine—brain cancer	0.00099	0.014	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Temozolomide—brain cancer	0.000983	0.0139	CcSEcCtD
Enzalutamide—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.000961	0.0205	CbGpPWpGaD
Enzalutamide—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.000939	0.02	CbGpPWpGaD
Enzalutamide—Pollakiuria—Procarbazine—brain cancer	0.000931	0.0132	CcSEcCtD
Enzalutamide—Pneumonia—Procarbazine—brain cancer	0.000903	0.0128	CcSEcCtD
Enzalutamide—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.000903	0.0192	CbGpPWpGaD
Enzalutamide—Infection—Lomustine—brain cancer	0.000896	0.0127	CcSEcCtD
Enzalutamide—Thrombocytopenia—Lomustine—brain cancer	0.000884	0.0125	CcSEcCtD
Enzalutamide—Sepsis—Carmustine—brain cancer	0.000872	0.0123	CcSEcCtD
Enzalutamide—Haematuria—Procarbazine—brain cancer	0.000856	0.0121	CcSEcCtD
Enzalutamide—Epistaxis—Procarbazine—brain cancer	0.000847	0.012	CcSEcCtD
Enzalutamide—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000814	0.0173	CbGpPWpGaD
Enzalutamide—Injury—Carmustine—brain cancer	0.000793	0.0112	CcSEcCtD
Enzalutamide—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000782	0.0167	CbGpPWpGaD
Enzalutamide—Amnesia—Carmustine—brain cancer	0.000776	0.011	CcSEcCtD
Enzalutamide—Hot flush—Temozolomide—brain cancer	0.000753	0.0107	CcSEcCtD
Enzalutamide—Amnesia—Temozolomide—brain cancer	0.00075	0.0106	CcSEcCtD
Enzalutamide—Menopausal symptoms—Temozolomide—brain cancer	0.000747	0.0106	CcSEcCtD
Enzalutamide—Neutropenia—Hydroxyurea—brain cancer	0.000729	0.0103	CcSEcCtD
Enzalutamide—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000726	0.0155	CbGpPWpGaD
Enzalutamide—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000698	0.0149	CbGpPWpGaD
Enzalutamide—Infestation NOS—Hydroxyurea—brain cancer	0.000695	0.00984	CcSEcCtD
Enzalutamide—Infestation—Hydroxyurea—brain cancer	0.000695	0.00984	CcSEcCtD
Enzalutamide—Sepsis—Etoposide—brain cancer	0.000674	0.00954	CcSEcCtD
Enzalutamide—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000668	0.0142	CbGpPWpGaD
Enzalutamide—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00066	0.0141	CbGpPWpGaD
Enzalutamide—Dry skin—Temozolomide—brain cancer	0.000646	0.00915	CcSEcCtD
Enzalutamide—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000645	0.0137	CbGpPWpGaD
Enzalutamide—Muscular weakness—Carmustine—brain cancer	0.000643	0.00911	CcSEcCtD
Enzalutamide—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000642	0.0137	CbGpPWpGaD
Enzalutamide—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000629	0.0134	CbGpPWpGaD
Enzalutamide—Leukopenia—Procarbazine—brain cancer	0.000628	0.0089	CcSEcCtD
Enzalutamide—Muscular weakness—Temozolomide—brain cancer	0.000622	0.0088	CcSEcCtD
Enzalutamide—AR—Notch-mediated HES/HEY network—HEY1—brain cancer	0.000609	0.013	CbGpPWpGaD
Enzalutamide—Convulsion—Procarbazine—brain cancer	0.000608	0.00861	CcSEcCtD
Enzalutamide—Hypertension—Procarbazine—brain cancer	0.000606	0.00858	CcSEcCtD
Enzalutamide—Arthralgia—Procarbazine—brain cancer	0.000598	0.00846	CcSEcCtD
Enzalutamide—Anxiety—Procarbazine—brain cancer	0.000596	0.00843	CcSEcCtD
Enzalutamide—Neutropenia—Carmustine—brain cancer	0.000589	0.00834	CcSEcCtD
Enzalutamide—Bronchitis—Temozolomide—brain cancer	0.000586	0.00829	CcSEcCtD
Enzalutamide—Neutropenia—Temozolomide—brain cancer	0.00057	0.00806	CcSEcCtD
Enzalutamide—Infection—Procarbazine—brain cancer	0.000569	0.00806	CcSEcCtD
Enzalutamide—Angiopathy—Hydroxyurea—brain cancer	0.000566	0.00802	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Temozolomide—brain cancer	0.000566	0.00801	CcSEcCtD
Enzalutamide—Pneumonia—Carmustine—brain cancer	0.000565	0.008	CcSEcCtD
Enzalutamide—Pollakiuria—Temozolomide—brain cancer	0.000563	0.00797	CcSEcCtD
Enzalutamide—Thrombocytopenia—Procarbazine—brain cancer	0.000561	0.00794	CcSEcCtD
Enzalutamide—Pneumonia—Temozolomide—brain cancer	0.000546	0.00773	CcSEcCtD
Enzalutamide—Infestation—Temozolomide—brain cancer	0.000543	0.00769	CcSEcCtD
Enzalutamide—Infestation NOS—Temozolomide—brain cancer	0.000543	0.00769	CcSEcCtD
Enzalutamide—AR—FOXA1 transcription factor network—SHH—brain cancer	0.000535	0.0114	CbGpPWpGaD
Enzalutamide—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000522	0.00739	CcSEcCtD
Enzalutamide—Insomnia—Procarbazine—brain cancer	0.000518	0.00734	CcSEcCtD
Enzalutamide—Paraesthesia—Procarbazine—brain cancer	0.000514	0.00728	CcSEcCtD
Enzalutamide—Sinusitis—Temozolomide—brain cancer	0.00051	0.00721	CcSEcCtD
Enzalutamide—Hypoaesthesia—Carmustine—brain cancer	0.000502	0.00711	CcSEcCtD
Enzalutamide—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000499	0.0106	CbGpPWpGaD
Enzalutamide—Oedema peripheral—Carmustine—brain cancer	0.000497	0.00704	CcSEcCtD
Enzalutamide—Connective tissue disorder—Carmustine—brain cancer	0.000496	0.00702	CcSEcCtD
Enzalutamide—Fatigue—Procarbazine—brain cancer	0.000494	0.00699	CcSEcCtD
Enzalutamide—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000487	0.0104	CbGpPWpGaD
Enzalutamide—Leukopenia—Hydroxyurea—brain cancer	0.000486	0.00688	CcSEcCtD
Enzalutamide—Hypoaesthesia—Temozolomide—brain cancer	0.000485	0.00687	CcSEcCtD
Enzalutamide—Pharyngitis—Temozolomide—brain cancer	0.000484	0.00685	CcSEcCtD
Enzalutamide—Urinary tract disorder—Temozolomide—brain cancer	0.000481	0.00682	CcSEcCtD
Enzalutamide—AR—Nuclear Receptors—ESR2—brain cancer	0.000481	0.0103	CbGpPWpGaD
Enzalutamide—Oedema peripheral—Temozolomide—brain cancer	0.00048	0.0068	CcSEcCtD
Enzalutamide—Connective tissue disorder—Temozolomide—brain cancer	0.000479	0.00678	CcSEcCtD
Enzalutamide—Urethral disorder—Temozolomide—brain cancer	0.000478	0.00677	CcSEcCtD
Enzalutamide—Convulsion—Hydroxyurea—brain cancer	0.000471	0.00666	CcSEcCtD
Enzalutamide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000464	0.00987	CbGpPWpGaD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000459	0.0065	CcSEcCtD
Enzalutamide—Neutropenia—Etoposide—brain cancer	0.000456	0.00645	CcSEcCtD
Enzalutamide—Angiopathy—Temozolomide—brain cancer	0.000442	0.00626	CcSEcCtD
Enzalutamide—Mental disorder—Carmustine—brain cancer	0.000442	0.00626	CcSEcCtD
Enzalutamide—Infection—Hydroxyurea—brain cancer	0.00044	0.00624	CcSEcCtD
Enzalutamide—Pneumonia—Etoposide—brain cancer	0.000437	0.00619	CcSEcCtD
Enzalutamide—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000437	0.0093	CbGpPWpGaD
Enzalutamide—Nervous system disorder—Hydroxyurea—brain cancer	0.000435	0.00616	CcSEcCtD
Enzalutamide—Infestation—Etoposide—brain cancer	0.000435	0.00615	CcSEcCtD
Enzalutamide—Infestation NOS—Etoposide—brain cancer	0.000435	0.00615	CcSEcCtD
Enzalutamide—Thrombocytopenia—Hydroxyurea—brain cancer	0.000434	0.00615	CcSEcCtD
Enzalutamide—Skin disorder—Hydroxyurea—brain cancer	0.000431	0.0061	CcSEcCtD
Enzalutamide—Mental disorder—Temozolomide—brain cancer	0.000427	0.00605	CcSEcCtD
Enzalutamide—Back pain—Carmustine—brain cancer	0.000425	0.00601	CcSEcCtD
Enzalutamide—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00042	0.00894	CbGpPWpGaD
Enzalutamide—Asthenia—Procarbazine—brain cancer	0.000411	0.00582	CcSEcCtD
Enzalutamide—Back pain—Temozolomide—brain cancer	0.000411	0.00581	CcSEcCtD
Enzalutamide—Pruritus—Procarbazine—brain cancer	0.000405	0.00574	CcSEcCtD
Enzalutamide—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000399	0.0085	CbGpPWpGaD
Enzalutamide—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000394	0.00839	CbGpPWpGaD
Enzalutamide—Leukopenia—Carmustine—brain cancer	0.000393	0.00557	CcSEcCtD
Enzalutamide—Diarrhoea—Procarbazine—brain cancer	0.000392	0.00555	CcSEcCtD
Enzalutamide—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000391	0.00832	CbGpPWpGaD
Enzalutamide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00039	0.00831	CbGpPWpGaD
Enzalutamide—Hypoaesthesia—Etoposide—brain cancer	0.000388	0.0055	CcSEcCtD
Enzalutamide—Urinary tract disorder—Etoposide—brain cancer	0.000385	0.00545	CcSEcCtD
Enzalutamide—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000385	0.0082	CbGpPWpGaD
Enzalutamide—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000383	0.00542	CcSEcCtD
Enzalutamide—Urethral disorder—Etoposide—brain cancer	0.000382	0.00541	CcSEcCtD
Enzalutamide—Fatigue—Hydroxyurea—brain cancer	0.000382	0.00541	CcSEcCtD
Enzalutamide—Vertigo—Temozolomide—brain cancer	0.000381	0.0054	CcSEcCtD
Enzalutamide—Convulsion—Carmustine—brain cancer	0.000381	0.00539	CcSEcCtD
Enzalutamide—AR—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00038	0.0081	CbGpPWpGaD
Enzalutamide—Leukopenia—Temozolomide—brain cancer	0.00038	0.00538	CcSEcCtD
Enzalutamide—Hypertension—Carmustine—brain cancer	0.000379	0.00537	CcSEcCtD
Enzalutamide—Dizziness—Procarbazine—brain cancer	0.000379	0.00536	CcSEcCtD
Enzalutamide—Anxiety—Carmustine—brain cancer	0.000373	0.00528	CcSEcCtD
Enzalutamide—Convulsion—Temozolomide—brain cancer	0.000368	0.00521	CcSEcCtD
Enzalutamide—Hypertension—Temozolomide—brain cancer	0.000366	0.00519	CcSEcCtD
Enzalutamide—AR—SIDS Susceptibility Pathways—HES5—brain cancer	0.000365	0.00778	CbGpPWpGaD
Enzalutamide—Arthralgia—Temozolomide—brain cancer	0.000361	0.00512	CcSEcCtD
Enzalutamide—Anxiety—Temozolomide—brain cancer	0.00036	0.0051	CcSEcCtD
Enzalutamide—Headache—Procarbazine—brain cancer	0.000359	0.00508	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000359	0.00508	CcSEcCtD
Enzalutamide—Infection—Carmustine—brain cancer	0.000356	0.00504	CcSEcCtD
Enzalutamide—Angiopathy—Etoposide—brain cancer	0.000354	0.00501	CcSEcCtD
Enzalutamide—Thrombocytopenia—Carmustine—brain cancer	0.000351	0.00497	CcSEcCtD
Enzalutamide—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000349	0.00743	CbGpPWpGaD
Enzalutamide—AR—Coregulation of Androgen receptor activity—CDK6—brain cancer	0.000348	0.00741	CbGpPWpGaD
Enzalutamide—Infection—Temozolomide—brain cancer	0.000344	0.00487	CcSEcCtD
Enzalutamide—Nervous system disorder—Temozolomide—brain cancer	0.00034	0.00481	CcSEcCtD
Enzalutamide—Thrombocytopenia—Temozolomide—brain cancer	0.000339	0.0048	CcSEcCtD
Enzalutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000338	0.00719	CbGpPWpGaD
Enzalutamide—Skin disorder—Temozolomide—brain cancer	0.000336	0.00476	CcSEcCtD
Enzalutamide—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000333	0.0071	CbGpPWpGaD
Enzalutamide—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000331	0.00706	CbGpPWpGaD
Enzalutamide—Back pain—Etoposide—brain cancer	0.000329	0.00465	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Carmustine—brain cancer	0.000327	0.00462	CcSEcCtD
Enzalutamide—Insomnia—Carmustine—brain cancer	0.000324	0.00459	CcSEcCtD
Enzalutamide—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000324	0.00689	CbGpPWpGaD
Enzalutamide—Paraesthesia—Carmustine—brain cancer	0.000322	0.00456	CcSEcCtD
Enzalutamide—Asthenia—Hydroxyurea—brain cancer	0.000318	0.0045	CcSEcCtD
Enzalutamide—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000316	0.00673	CbGpPWpGaD
Enzalutamide—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000316	0.00447	CcSEcCtD
Enzalutamide—AR—Notch-mediated HES/HEY network—HES1—brain cancer	0.000315	0.00671	CbGpPWpGaD
Enzalutamide—Insomnia—Temozolomide—brain cancer	0.000313	0.00444	CcSEcCtD
Enzalutamide—Paraesthesia—Temozolomide—brain cancer	0.000311	0.0044	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Carmustine—brain cancer	0.000309	0.00438	CcSEcCtD
Enzalutamide—Vertigo—Etoposide—brain cancer	0.000305	0.00432	CcSEcCtD
Enzalutamide—Leukopenia—Etoposide—brain cancer	0.000304	0.0043	CcSEcCtD
Enzalutamide—Diarrhoea—Hydroxyurea—brain cancer	0.000303	0.00429	CcSEcCtD
Enzalutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000302	0.00642	CbGpPWpGaD
Enzalutamide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.0003	0.00639	CbGpPWpGaD
Enzalutamide—Gastrointestinal disorder—Temozolomide—brain cancer	0.000299	0.00423	CcSEcCtD
Enzalutamide—Fatigue—Temozolomide—brain cancer	0.000299	0.00423	CcSEcCtD
Enzalutamide—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000298	0.00634	CbGpPWpGaD
Enzalutamide—AR—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.000297	0.00633	CbGpPWpGaD
Enzalutamide—Convulsion—Etoposide—brain cancer	0.000294	0.00417	CcSEcCtD
Enzalutamide—Hypertension—Etoposide—brain cancer	0.000293	0.00415	CcSEcCtD
Enzalutamide—Dizziness—Hydroxyurea—brain cancer	0.000293	0.00415	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000287	0.00407	CcSEcCtD
Enzalutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000286	0.00608	CbGpPWpGaD
Enzalutamide—Headache—Hydroxyurea—brain cancer	0.000278	0.00393	CcSEcCtD
Enzalutamide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000277	0.00591	CbGpPWpGaD
Enzalutamide—Infection—Etoposide—brain cancer	0.000275	0.0039	CcSEcCtD
Enzalutamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000274	0.00583	CbGpPWpGaD
Enzalutamide—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000274	0.00583	CbGpPWpGaD
Enzalutamide—Thrombocytopenia—Etoposide—brain cancer	0.000271	0.00384	CcSEcCtD
Enzalutamide—Skin disorder—Etoposide—brain cancer	0.000269	0.00381	CcSEcCtD
Enzalutamide—Asthenia—Carmustine—brain cancer	0.000257	0.00364	CcSEcCtD
Enzalutamide—Paraesthesia—Etoposide—brain cancer	0.000249	0.00352	CcSEcCtD
Enzalutamide—Asthenia—Temozolomide—brain cancer	0.000249	0.00352	CcSEcCtD
Enzalutamide—Diarrhoea—Carmustine—brain cancer	0.000245	0.00347	CcSEcCtD
Enzalutamide—Pruritus—Temozolomide—brain cancer	0.000245	0.00347	CcSEcCtD
Enzalutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000244	0.00521	CbGpPWpGaD
Enzalutamide—Gastrointestinal disorder—Etoposide—brain cancer	0.000239	0.00339	CcSEcCtD
Enzalutamide—Fatigue—Etoposide—brain cancer	0.000239	0.00338	CcSEcCtD
Enzalutamide—Dizziness—Carmustine—brain cancer	0.000237	0.00336	CcSEcCtD
Enzalutamide—Diarrhoea—Temozolomide—brain cancer	0.000237	0.00336	CcSEcCtD
Enzalutamide—Dizziness—Temozolomide—brain cancer	0.000229	0.00324	CcSEcCtD
Enzalutamide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000225	0.00479	CbGpPWpGaD
Enzalutamide—Headache—Carmustine—brain cancer	0.000225	0.00318	CcSEcCtD
Enzalutamide—Headache—Temozolomide—brain cancer	0.000217	0.00307	CcSEcCtD
Enzalutamide—Asthenia—Etoposide—brain cancer	0.000199	0.00282	CcSEcCtD
Enzalutamide—AR—Androgen receptor signaling pathway—SIRT1—brain cancer	0.000196	0.00418	CbGpPWpGaD
Enzalutamide—Pruritus—Etoposide—brain cancer	0.000196	0.00278	CcSEcCtD
Enzalutamide—AR—Androgen receptor signaling pathway—CCNE1—brain cancer	0.000194	0.00413	CbGpPWpGaD
Enzalutamide—Diarrhoea—Etoposide—brain cancer	0.00019	0.00268	CcSEcCtD
Enzalutamide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.00019	0.00404	CbGpPWpGaD
Enzalutamide—Dizziness—Etoposide—brain cancer	0.000183	0.00259	CcSEcCtD
Enzalutamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000181	0.00386	CbGpPWpGaD
Enzalutamide—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000179	0.00381	CbGpPWpGaD
Enzalutamide—Headache—Etoposide—brain cancer	0.000174	0.00246	CcSEcCtD
Enzalutamide—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000172	0.00366	CbGpPWpGaD
Enzalutamide—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000169	0.00361	CbGpPWpGaD
Enzalutamide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000169	0.0036	CbGpPWpGaD
Enzalutamide—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000168	0.00358	CbGpPWpGaD
Enzalutamide—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000166	0.00353	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000165	0.00352	CbGpPWpGaD
Enzalutamide—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.00016	0.00341	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000157	0.00334	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000156	0.00331	CbGpPWpGaD
Enzalutamide—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000154	0.00328	CbGpPWpGaD
Enzalutamide—AR—Coregulation of Androgen receptor activity—CDKN2A—brain cancer	0.000153	0.00327	CbGpPWpGaD
Enzalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—brain cancer	0.000152	0.00324	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000149	0.00317	CbGpPWpGaD
Enzalutamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000147	0.00313	CbGpPWpGaD
Enzalutamide—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000145	0.0031	CbGpPWpGaD
Enzalutamide—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000143	0.00306	CbGpPWpGaD
Enzalutamide—AR—Notch-mediated HES/HEY network—STAT3—brain cancer	0.000138	0.00294	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	0.000137	0.00292	CbGpPWpGaD
Enzalutamide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000137	0.00291	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000132	0.00282	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000131	0.00279	CbGpPWpGaD
Enzalutamide—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.00013	0.00277	CbGpPWpGaD
Enzalutamide—AR—Coregulation of Androgen receptor activity—CCND1—brain cancer	0.00013	0.00276	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000129	0.00274	CbGpPWpGaD
Enzalutamide—AR—Coregulation of Androgen receptor activity—CTNNB1—brain cancer	0.000128	0.00273	CbGpPWpGaD
Enzalutamide—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000128	0.00273	CbGpPWpGaD
Enzalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—brain cancer	0.000124	0.00263	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—HES1—brain cancer	0.000121	0.00257	CbGpPWpGaD
Enzalutamide—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.000119	0.00254	CbGpPWpGaD
Enzalutamide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000118	0.00252	CbGpPWpGaD
Enzalutamide—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000118	0.00251	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—SOD2—brain cancer	0.000112	0.00238	CbGpPWpGaD
Enzalutamide—AR—Androgen receptor signaling pathway—RELA—brain cancer	0.000109	0.00232	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000109	0.00231	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000107	0.00227	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000105	0.00224	CbGpPWpGaD
Enzalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—brain cancer	0.000104	0.00222	CbGpPWpGaD
Enzalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—brain cancer	0.000103	0.0022	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	9.78e-05	0.00208	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—CDK4—brain cancer	9.72e-05	0.00207	CbGpPWpGaD
Enzalutamide—AR—Androgen receptor signaling pathway—CCND1—brain cancer	9.58e-05	0.00204	CbGpPWpGaD
Enzalutamide—AR—Androgen receptor signaling pathway—CTNNB1—brain cancer	9.49e-05	0.00202	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	9.32e-05	0.00198	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—SOD2—brain cancer	8.86e-05	0.00189	CbGpPWpGaD
Enzalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—brain cancer	8.37e-05	0.00178	CbGpPWpGaD
Enzalutamide—AR—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	8.29e-05	0.00176	CbGpPWpGaD
Enzalutamide—AR—Androgen receptor signaling pathway—STAT3—brain cancer	8.27e-05	0.00176	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—PDGFRA—brain cancer	8.08e-05	0.00172	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	8.06e-05	0.00172	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—RELA—brain cancer	7.93e-05	0.00169	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—CYP2C9—brain cancer	7.81e-05	0.00166	CbGpPWpGaD
Enzalutamide—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	7.7e-05	0.00164	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—MPL—brain cancer	7.68e-05	0.00164	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—APC—brain cancer	7.58e-05	0.00161	CbGpPWpGaD
Enzalutamide—AR—Androgen receptor signaling pathway—EGFR—brain cancer	7.52e-05	0.0016	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—S100A10—brain cancer	7.36e-05	0.00157	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	6.74e-05	0.00143	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	6.6e-05	0.0014	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—ESR2—brain cancer	6.57e-05	0.0014	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—RELA—brain cancer	6.45e-05	0.00137	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	6.39e-05	0.00136	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	6.37e-05	0.00136	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—CCND1—brain cancer	6.28e-05	0.00134	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—NOTCH2—brain cancer	6.22e-05	0.00133	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	6.22e-05	0.00132	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—CTNNB1—brain cancer	6.06e-05	0.00129	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	5.89e-05	0.00125	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—IL2—brain cancer	5.81e-05	0.00124	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.59e-05	0.00119	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	5.59e-05	0.00119	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.55e-05	0.00118	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	5.47e-05	0.00117	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	5.39e-05	0.00115	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—VEGFA—brain cancer	5.33e-05	0.00114	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	5.2e-05	0.00111	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—BSG—brain cancer	5.19e-05	0.0011	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	5.15e-05	0.0011	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—RELA—brain cancer	5.12e-05	0.00109	CbGpPWpGaD
Enzalutamide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	5.05e-05	0.00108	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—MYC—brain cancer	5.04e-05	0.00107	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.99e-05	0.00106	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	4.94e-05	0.00105	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—EGFR—brain cancer	4.92e-05	0.00105	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	4.53e-05	0.000966	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	4.43e-05	0.000943	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—IL2—brain cancer	4.41e-05	0.000939	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	4.34e-05	0.000924	CbGpPWpGaD
Enzalutamide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	4.32e-05	0.000921	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	4.29e-05	0.000913	CbGpPWpGaD
Enzalutamide—ALB—Platelet degranulation—VEGFA—brain cancer	4.23e-05	0.000901	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	4.17e-05	0.000889	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—TP53—brain cancer	4.14e-05	0.000881	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.08e-05	0.00087	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	4.08e-05	0.000869	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.06e-05	0.000865	CbGpPWpGaD
Enzalutamide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	4.03e-05	0.000859	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	3.99e-05	0.000849	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	3.8e-05	0.000809	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—VEGFA—brain cancer	3.75e-05	0.000798	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—TP53—brain cancer	3.73e-05	0.000794	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.65e-05	0.000776	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—DNMT1—brain cancer	3.52e-05	0.00075	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	3.43e-05	0.00073	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TRPC6—brain cancer	3.4e-05	0.000724	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.32e-05	0.000708	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	3.28e-05	0.000699	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—ESR2—brain cancer	3.16e-05	0.000674	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	3.14e-05	0.000668	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	3.09e-05	0.000658	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—NOTCH2—brain cancer	3e-05	0.000638	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	2.94e-05	0.000627	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP2C9—brain cancer	2.94e-05	0.000626	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP2C9—brain cancer	2.87e-05	0.000612	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.58e-05	0.000549	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—VAV1—brain cancer	2.55e-05	0.000543	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—SIRT1—brain cancer	2.55e-05	0.000542	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—BSG—brain cancer	2.5e-05	0.000532	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP2C9—brain cancer	2.49e-05	0.00053	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP2C9—brain cancer	2.47e-05	0.000527	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—BSG—brain cancer	2.44e-05	0.00052	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	2.4e-05	0.000511	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP2C9—brain cancer	2.22e-05	0.000473	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	2.21e-05	0.00047	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP2C9—brain cancer	2.17e-05	0.000462	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—IDH1—brain cancer	2.15e-05	0.000458	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.12e-05	0.000451	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—BSG—brain cancer	2.12e-05	0.000451	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—BSG—brain cancer	2.1e-05	0.000448	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—IDH1—brain cancer	2.1e-05	0.000447	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.1e-05	0.000447	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—MYC—brain cancer	2.07e-05	0.000441	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP2C9—brain cancer	2.04e-05	0.000435	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—BSG—brain cancer	1.89e-05	0.000402	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	1.88e-05	0.0004	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.85e-05	0.000394	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—BSG—brain cancer	1.84e-05	0.000393	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—IDH1—brain cancer	1.82e-05	0.000387	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—IDH1—brain cancer	1.81e-05	0.000385	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—BSG—brain cancer	1.74e-05	0.00037	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—BSG—brain cancer	1.72e-05	0.000367	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.7e-05	0.000362	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ENO2—brain cancer	1.7e-05	0.000362	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.66e-05	0.000354	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ENO2—brain cancer	1.66e-05	0.000354	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—IDH1—brain cancer	1.62e-05	0.000346	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PIK3CG—brain cancer	1.62e-05	0.000345	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—IDH1—brain cancer	1.58e-05	0.000338	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—IDH1—brain cancer	1.49e-05	0.000318	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.48e-05	0.000315	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—IDH1—brain cancer	1.48e-05	0.000315	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.47e-05	0.000314	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ENO2—brain cancer	1.44e-05	0.000306	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ENO2—brain cancer	1.43e-05	0.000305	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.4e-05	0.000297	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP2C9—brain cancer	1.34e-05	0.000284	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.32e-05	0.000282	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ENO2—brain cancer	1.28e-05	0.000273	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ENO2—brain cancer	1.25e-05	0.000267	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.21e-05	0.000257	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ENO2—brain cancer	1.18e-05	0.000251	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ENO2—brain cancer	1.17e-05	0.000249	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—IL2—brain cancer	1.14e-05	0.000242	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—BSG—brain cancer	1.14e-05	0.000242	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—MYC—brain cancer	9.98e-06	0.000213	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—IDH1—brain cancer	9.76e-06	0.000208	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—VEGFA—brain cancer	9.68e-06	0.000206	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CG—brain cancer	7.79e-06	0.000166	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ENO2—brain cancer	7.72e-06	0.000164	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CG—brain cancer	7.62e-06	0.000162	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TP53—brain cancer	7.31e-06	0.000156	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CG—brain cancer	6.6e-06	0.00014	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CG—brain cancer	6.56e-06	0.00014	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CG—brain cancer	5.89e-06	0.000125	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CG—brain cancer	5.75e-06	0.000122	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CG—brain cancer	5.42e-06	0.000115	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CG—brain cancer	5.37e-06	0.000114	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CG—brain cancer	3.54e-06	7.54e-05	CbGpPWpGaD
